Request Deal Involvement
Syngene to acquire multi-modal facility in Bangalore from Stelis Biopharma for $86m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
target
MULTI-MODAL FACILITY IN BANGALORE
bidder
SYNGENE
vendor
STELIS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite